(2S)-3-[[2-[[3-[5-(adamantane-1-carbonylamino)pentanoylamino]-5-guanidinobenzoyl]amino]acetyl]amino]-2-[[(2S)-1-(benzenesulfonyl)pyrrolidine-2-carbonyl]amino]propanoic acid

ID: ALA4794201

Chembl Id: CHEMBL4794201

PubChem CID: 162674063

Max Phase: Preclinical

Molecular Formula: C40H53N9O9S

Molecular Weight: 835.98

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)Nc1cc(NC(=O)CCCCNC(=O)C23CC4CC(CC(C4)C2)C3)cc(C(=O)NCC(=O)NC[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)c1

Standard InChI:  InChI=1S/C40H53N9O9S/c41-39(42)47-29-17-27(16-28(18-29)46-33(50)10-4-5-11-43-38(56)40-19-24-13-25(20-40)15-26(14-24)21-40)35(52)45-23-34(51)44-22-31(37(54)55)48-36(53)32-9-6-12-49(32)59(57,58)30-7-2-1-3-8-30/h1-3,7-8,16-18,24-26,31-32H,4-6,9-15,19-23H2,(H,43,56)(H,44,51)(H,45,52)(H,46,50)(H,48,53)(H,54,55)(H4,41,42,47)/t24?,25?,26?,31-,32-,40?/m0/s1

Standard InChI Key:  PCEMPIMHMWVATP-OONSMZQZSA-N

Alternative Forms

  1. Parent:

    ALA4794201

    ---

Associated Targets(Human)

ITGB1 Tclin Integrin alpha-5/beta-1 (686 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-V/beta-1 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-8 (181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 835.98Molecular Weight (Monoisotopic): 835.3687AlogP: 1.70#Rotatable Bonds: 18
Polar Surface Area: 282.08Molecular Species: ZWITTERIONHBA: 9HBD: 9
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.03CX Basic pKa: 9.03CX LogP: -0.97CX LogD: -0.98
Aromatic Rings: 2Heavy Atoms: 59QED Weighted: 0.06Np Likeness Score: -1.13

References

1. Sundaram A,Chen C,Isik Reed N,Liu S,Ki Yeon S,McIntosh J,Tang YZ,Yang H,Adler M,Beresis R,Seiple IB,Sheppard D,DeGrado WF,Jo H.  (2020)  Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness.,  30  (22): [PMID:33007395] [10.1016/j.bmcl.2020.127578]

Source